Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cerus Corp (NQ: CERS )

6.180 USD -0.170 (-2.68%)
Official Closing Price Updated: 5:00 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Cerus Corp

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
35 36 Next >
28 Stocks Moving In Wednesday's Pre-Market Session
Gainers Naked Brand Group Inc (NASDAQ: NAKD) shares rose 169.2 percent to $4.28 in pre-market trading. Caladrius Biosciences Inc ... 
Tags Energy BKYI SOL
From Benzinga
Cerus Presents Results of European Phase 3 Chronic Anemia Study at the 23rd Congress of European Hematology Association
Cerus Corporation (Nasdaq: CERS) announced that results from SPARC, the Company’s European Phase 3 study evaluating the efficacy and safety of INTERCEPT-treated red blood cells (RBCs) in thalassemia... 
From Business Wire News Releases
Cerus Announces Presentations Highlighting INTERCEPT Blood Systems at the 35th International Congress of the International Society of Blood Transfusion
Cerus Corporation (Nasdaq: CERS) today announced that it will make multiple presentations, including two oral abstracts, that will be featured at the 35th International Congress of the International... 
From Business Wire News Releases
Cerus Announces Additional BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells
Cerus Corporation (Nasdaq: CERS) today announced an amendment to the Company’s contract with the Biomedical Advanced Research and Development Authority (BARDA). The expansion of the agreement provides... 
From Business Wire News Releases
New Research Coverage Highlights Cerus, Health Insurance Innovations, Tetra Tech, Ferro, Dril-Quip, and MSC Industrial Direct — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cerus Corporation... 
From GlobeNewswire News Releases
Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags AMAG MNTA CERS
From Benzinga
54 Biggest Movers From Yesterday
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares surged 30.27 percent to close at $12.05 on Wednesday ... 
Tags COKE Trading Ideas Top Gainers
From Benzinga
Here's Why Cerus Corporation Stock Is Surging Today
A better-than-expected outlook after the company's first-quarter report is lifting more than spirits. 
Tags CERS Market News
From Motley Fool
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 ... 
Tags SRT AMDA CUTR
From Benzinga
Cerus Corporation Reports First Quarter 2018 Results
Cerus Corporation (Nasdaq:CERS) announced today financial results for the first quarter ended March 31, 2018, and raised its full year guidance for product revenue. 
From Business Wire News Releases
91.5% Return Seen to Date on SmarTrend Cerus Corp Call (CERS)
SmarTrend identified an Uptrend for Cerus Corp (NASDAQ:CERS) on October 2nd, 2017 at $2.84. In approximately 7 months, Cerus Corp has returned 91.55% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Cerus to Present at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday May 9, 2018
Cerus Corporation (Nasdaq: CERS) announced today that Dr. Laurence M. Corash, co-founder and chief scientific officer, and Lainie Corten, vice president of global marketing, are scheduled to present a... 
From Business Wire News Releases
Cerus to Release First Quarter 2018 Results on May 8, 2018
Cerus Corporation (Nasdaq:CERS) announced today that its first quarter results will be released on Tuesday, May 8, 2018, after the close of the stock market. The company will host a conference call and... 
From Business Wire News Releases
Cerus Announces Health Canada Approval of the INTERCEPT Blood System for Platelets
Cerus Corporation (Nasdaq: CERS) announced today that Health Canada has approved the commercialization of INTERCEPT Blood System for platelets. The INTERCEPT Blood System for platelets is intended for... 
From Business Wire News Releases
Uptrend Call Working As Cerus Corp Stock Rises 97.2% (CERS)
SmarTrend identified an Uptrend for Cerus Corp (NASDAQ:CERS) on October 2nd, 2017 at $2.84. In approximately 7 months, Cerus Corp has returned 97.18% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Commit To Purchase Cerus Corp. At $5, Earn 15.5% Annualized Using Options
Investors considering a purchase of Cerus Corp. (CERS) shares, but tentative about paying the going market price of $5.62/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
Uptrend Call Working As Cerus Corp Stock Rises 91.9% (CERS)
SmarTrend identified an Uptrend for Cerus Corp (NASDAQ:CERS) on October 2nd, 2017 at $2.84. In approximately 6 months, Cerus Corp has returned 91.90% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
87.3% Return Seen to Date on SmarTrend Cerus Corp Call (CERS)
SmarTrend identified an Uptrend for Cerus Corp (NASDAQ:CERS) on October 2nd, 2017 at $2.84. In approximately 6 months, Cerus Corp has returned 87.32% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
How The Pieces Add Up: XHE Targets $77
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BRIEF-Cerus’ Redes Phase 3 Red Blood Cell Study Expands Into The Continental U.S.
* ’ REDES PHASE 3 RED BLOOD CELL STUDY EXPANDS INTO THE CONTINENTAL U.S. 
Tags companyNews
From Reuters: Company News
Cerus’ RedeS Phase 3 Red Blood Cell Study Expands Into the Continental U.S.
Cerus Corporation (NASDAQ: CERS) announced today that Baylor St. Luke’s Medical Center in Houston became the first center in the continental U.S. to enroll patients in Cerus’ RedeS study. RedeS is a... 
From Business Wire News Releases
Cerus Corporation, Shares Up 39% in the Past Month, Analysts Review, INTERCEPT
From ACCESSWIRE
Cerus Corp Has Returned 104.2% Since SmarTrend Recommendation (CERS)
SmarTrend identified an Uptrend for Cerus Corp (NASDAQ:CERS) on October 2nd, 2017 at $2.84. In approximately 6 months, Cerus Corp has returned 104.23% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
Friday 3/16 Insider Buying Report: CERS, QSII
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. 
Tags Stocks
From Market News Video
Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer
Cerus Corporation (NASDAQ: CERS) announced today that The Community Blood Center (CBC) of Appleton, Wisconsin received approval by the U.S. Food and Drug Administration (FDA) on their Biologics License... 
From Business Wire News Releases
Cerus Corporation Reports Record Fourth Quarter and Year End 2017 Results
Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and year ended December 31, 2017. 
From Business Wire News Releases
Cerus to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018
Cerus Corporation (NASDAQ: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, is scheduled to present a corporate update at the Cowen and Company 38th... 
From Business Wire News Releases
Cerus to Release Fourth Quarter and Year End 2017 Results on March 8, 2018
Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and year end results for 2017 will be released on Thursday, March 8, 2018, after the close of the stock market. The company will... 
From Business Wire News Releases
Detailed Research: Economic Perspectives on REV Group, CoreLogic, Nu Skin Enterprises, Torchmark, Evertec, and Cerus — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of REV Group, Inc.... 
From GlobeNewswire News Releases
Look Under The Hood: XHE Has 15% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
35 36 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.